Core Insights - The stock of Steady Medical closed at 48.68 yuan, up 6.06%, with a latest price-to-book ratio of 2.49, marking a new low in 460 days, and a total market capitalization of 28.348 billion yuan [1] - As of the Q3 2024 report, 55 institutions hold shares in Steady Medical, with a total of 19.4574 million shares valued at 896 million yuan [1] - Steady Medical specializes in the research, production, and sales of cotton-based products across various sectors, including medical, personal care, and home care [1] Financial Performance - For Q3 2024, the company reported revenue of 6.07 billion yuan, a year-on-year increase of 0.99%, and a net profit of 553 million yuan, reflecting a year-on-year decrease of 74.25%, with a gross profit margin of 48.14% [1] Market Position - Steady Medical has consistently ranked among the top three exporters of medical dressings in China for several years, with its "winner" brand products available in over 2,000 hospitals and nearly 40,000 pharmacies across the country [1] - The "winner" brand has also achieved coverage in all public hospitals and most private hospitals in Hong Kong [1] Valuation Metrics - The company has a trailing twelve months (TTM) price-to-earnings (PE) ratio of -27.95 and a static PE ratio of 48.84, with a market capitalization of 28.348 billion yuan [2] - The industry average PE TTM is 48.92, while the industry median is 39.80 [2]

Group 1 - The core viewpoint of the articles highlights the performance and market position of the company, Steady Medical, which has seen a slight increase in stock price and maintains a significant market capitalization [1][2] - As of March 26, the company's stock closed at 44.84 yuan, up 1.06%, with a latest price-to-book ratio of 2.30 and a total market value of 26.112 billion yuan [1] - The company has a diverse product range including high-end wound dressings, traditional wound care products, and personal care items, and has consistently ranked among the top three exporters of medical dressings in China [1] Group 2 - For the third quarter of 2024, the company reported a revenue of 6.070 billion yuan, reflecting a year-on-year increase of 0.99%, while net profit decreased by 74.25% to 553 million yuan [2] - The company's sales gross margin stands at 48.14%, indicating a relatively healthy profitability despite the decline in net profit [2] - The company has a shareholder base of 28,966, with an average holding value of 352,800 yuan and an average shareholding quantity of 27,600 shares [1]

发布机构 证监会 发文日期 名 称 奥美医疗用品股份有限公司首次公开发行股票招股说明书（申报稿2017年11月14日报送） 文 号 主 题 词 | | | 奥美医疗用品股份有限公司首次公开发行股票招股说明书（申报稿 2017年11月14日报送） 根据《证券法》第二十一条和《首次公开发行股票并上市管理办法》第五十八条、《首次公开发行股票并在创业 板上市管理办法》第四十条的规定，申请文件受理后、发行审核委员会审核前，发行人应当将招股说明书（申报稿） 在中国证监会网站预先披露。 【打印】 【关闭窗口】 ...